Get the Stockscreener App
264.30
0.89%
-2.285
Insulet Corporation stock is traded at $264.30, with a volume of 74,993.
It is down -0.89% in the last 24 hours and up +11.72% over the past month.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.
See More
Previous Close:
$266.58
Open:
$267.43
24h Volume:
74,993
Relative Volume:
0.12
Market Cap:
$18.70B
Revenue:
$1.87B
Net Income/Loss:
$395.30M
P/E Ratio:
154.56
EPS:
1.71
Net Cash Flow:
$182.40M
1W Performance:
+1.16%
1M Performance:
+11.72%
6M Performance:
+44.54%
1Y Performance:
+45.71%
1-Day Range:
$262.46
$267.43
1-Week Range:
$257.43
$267.43
52-Week Range:
$160.19
$279.40
Insulet Corporation Stock (PODD) Company Profile
Name
Insulet Corporation
Sector
Industry
Phone
978-600-7000
Address
100 NAGOG PARK, ACTON, MA
Compare PODD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| PODD | 264.42 | 18.70B | 1.87B | 395.30M | 182.40M | 1.71 |
| ABT | 115.97 | 201.34B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 388.22 | 146.32B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 91.44 | 132.22B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 84.65 | 107.39B | 33.00B | 4.29B | 5.50B | 2.71 |
| EW | 70.05 | 41.01B | 6.60B | 4.16B | 490.10M | 2.34 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-02-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-21-23 | Upgrade | Citigroup | Neutral → Buy |
| Aug-21-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-11-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-01-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-19-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Jul-28-20 | Initiated | Wells Fargo | Overweight |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-03-20 | Initiated | BofA/Merrill | Neutral |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Dec-10-19 | Initiated | CFRA | Sell |
| Oct-23-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-14-19 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-04-19 | Downgrade | UBS | Buy → Neutral |
| Oct-03-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-06-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-10-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| May-06-19 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-20-18 | Initiated | Berenberg | Buy |
| Feb-22-18 | Reiterated | Barclays | Overweight |
| Jan-08-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-03-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Sep-15-17 | Initiated | Barclays | Overweight |
View All
Insulet Corporation Stock (PODD) Latest News
Brown Capital Management LLC Sells 11,147 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet adds Abbott’s FreeStyle Libre 2 Plus to Omnipod 5’s compatibility roster - Yahoo Finance
Insulet: Superb Business Growth, Starting Valuations Outsized Risk (NASDAQ:PODD) - Seeking Alpha
Segall Bryant & Hamill LLC Has $14.68 Million Stake in Insulet Co. (NASDAQ:PODD) - MarketBeat
Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest Investment For Growth - Insider Monkey
Insulet Corporation: Significant Opportunities, Significant ThreatsI'm On The Sidelines - Seeking Alpha
Indexes Show More Strength, Pare Losses: Blue Owl, Chewy, Insulet In FocusVideoIBD - Investor's Business Daily
Insulet To Present At Wolfe Research Healthcare Conference; Webcast At 12:00 PM ET - Nasdaq
Buy Profitable S&P 500 Stocks as the Index Tops 6000: NVIDIA & 2 More - MSN
Insulet Corporation Announces Omnipod® 5 System Now Compatible with Abbott's FreeStyle Libre 2 Plus Sensor in the U.S - Marketscreener.com
This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - MSN
15,111 Shares in Insulet Co. (NASDAQ:PODD) Acquired by LMR Partners LLP - MarketBeat
Insulet Co. (NASDAQ:PODD) Shares Purchased by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Insulet Corp - Cyber Magazine
Mizuho Securities USA LLC Boosts Position in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet's (NASDAQ:PODD) Solid Profits Have Weak Fundamentals - Yahoo Finance
GSA Capital Partners LLP Acquires Shares of 4,370 Insulet Co. (NASDAQ:PODD) - MarketBeat
Commit To Buy Insulet At $260, Earn 15.4% Annualized Using Options - Nasdaq
Insulet to Present at Major Healthcare Conferences, Showcasing Omnipod 5 Innovation | PODD Stock News - StockTitan
William Blair Has Optimistic Outlook of Insulet Q3 Earnings - MarketBeat
Insulet Co. (NASDAQ:PODD) Shares Bought by Principal Financial Group Inc. - MarketBeat
Insulet corp director Luciana Borio sells $139,598 in stock - Investing.com
Insider Sale: Director Luciana Borio Sells Shares of Insulet Cor - GuruFocus.com
Insulet corp director Luciana Borio sells $139,598 in stock By Investing.com - Investing.com UK
William Blair Issues Optimistic Outlook for Insulet Earnings - MarketBeat
Insulet Co. (NASDAQ:PODD) Shares Sold by Los Angeles Capital Management LLC - MarketBeat
Capital Research Global Investors Expands Stake in Insulet Corp - GuruFocus.com
Insulet's SWOT analysis: diabetes tech leader faces competition in pump market - Investing.com
Zacks.com featured highlights include NVIDIA, Insulet and Howmet Aerospace - Yahoo Finance
Insulet Corporation Rings the Closing Bell - Nasdaq
Why Insulet (PODD) is a Top Growth Stock for the Long-Term - Yahoo Finance
Insulet Co. (NASDAQ:PODD) Shares Acquired by Baillie Gifford & Co. - MarketBeat
PODD Stock Gains on Q3 Earnings and Revenue Beat, '24 Sales View Up - Yahoo Finance
Insulet price target raised to $317 from $234 at Morgan Stanley - Yahoo Finance
Barclays raises Insulet stock price target following robust Q3 beat By Investing.com - Investing.com Canada
Barclays raises Insulet stock price target following robust Q3 beat - Investing.com India
Barclays Increases Insulet (NASDAQ:PODD) Price Target to $234.00 - MarketBeat
Morgan Stanley Raises Insulet (NASDAQ:PODD) Price Target to $317.00 - MarketBeat
Insulet Corporation (PODD) PT Raised to $234 at Barclays - StreetInsider.com
Insulet Q3 2024 revenue up 25.7% to USD 543.9M - Medical Buyer
Leerink Partnrs Analysts Cut Earnings Estimates for Insulet - MarketBeat
Ownership Capital B.V. Decreases Stock Position in Insulet Co. (NASDAQ:PODD) - MarketBeat
Results: Insulet Corporation Beat Earnings Expectations And Analysts Now Have New Forecasts - Yahoo Finance
Insulet (NASDAQ:PODD) Shares Up 10.7% After Analyst Upgrade - MarketBeat
Insulet Corporation (NASDAQ:PODD) Q3 2024 Earnings Call Transcript - Insider Monkey
Insulet Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
AEGON ASSET MANAGEMENT UK Plc Has $31.51 Million Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat
Robeco Institutional Asset Management B.V. Cuts Stake in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Raises Revenue Forecast As Demand For Omnipod Grows - Finimize
Earnings call: Insulet Corporation touts strong Q3 growth and type 2 expansion - Investing.com
Insulet (NASDAQ:PODD) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
Insulet Corporation Stock (PODD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.08%
0.99%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):